We found that in BRCA (Fig. 2a, b), LUAD (Fig. 2c, d), and lower-grade glioma (LGG) (Fig. 2e, f), BRD4 expression was positively correlated with both poor overall survival (OS) and disease-free survival (DFS). This evidence concerns the gene BRD4 and central nervous system cancer.